XML 25 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 10 - Stock-based Compensation
9 Months Ended
Oct. 31, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
10.
  STOCK-BASED COMPENSATION
 
The Company
’s equity awards consist of RSUs and SARs. For a description of the Company’s stock-based compensation plans, see Note
5
“Stock-Based Compensation” in Notes to Consolidated Financial Statements included in the Annual Report on Form
10
-K for the year ended
January 31, 2017.
 
Stock-Based Compensation
 
The following table sets forth reported stock-based compensation expense for the
three
and
 
nine
months ended
October 31, 2017
and
2016:
 
   
Three Months Ended
October
31,
   
Nine
Months Ended
October
31,
 
   
2017
   
2016
   
2017
   
2016
 
   
(in thousands)
   
(in thousands)
 
Cost of subscription
  $
37
    $
32
    $
98
    $
81
 
Cost of maintenance and other revenue
   
107
     
80
     
279
     
219
 
Cost of professional services
   
309
     
232
     
803
     
618
 
Sales and marketing
   
421
     
306
     
1,106
     
904
 
Research and development
   
338
     
262
     
895
     
748
 
General and administrative
   
1,099
     
908
     
3,490
     
2,951
 
Total stock-based compensation expense
  $
2,311
    $
1,820
    $
6,671
    $
5,521
 
 
 
RSU Information
 
The estimated fair value of RSUs was calculated based on the closing price of the Company
’s common stock on the date of grant, reduced by the present value of dividends foregone during the vesting period.
 
The following table summarizes the activity for RSUs for the
nine
months ended
October 31, 2017:
 
 
   
RSUs
   
Weighted
Average
Grant Date
Fair Value
 
   
(in thousands)
   
 
 
 
Outstanding
at January 31, 2017
   
623
    $
20.56
 
Granted
   
294
     
30.68
 
Released
(1)
   
(245
)
   
20.44
 
Forfeited
   
(10
)
   
20.99
 
Outstanding at
October 31, 2017
   
662
    $
25.07
 
_________________________
 
(
1
)
The
number of RSUs released includes shares withheld on behalf of employees to satisfy the minimum statutory tax withholding requirements.
 
The Company withholds a portion of the released shares as consideration for the Company
’s payment of applicable employee income taxes. During the
three
months ended
October 31, 2017,
the Company withheld
2,000
shares for payment of these taxes at a value of
$62,000.
During the
nine
months ended
October 31, 2017,
the Company withheld
74,000
shares for payment of these taxes at a value of
$2.4
million.
 
 
Total unrecognized compensation cost related to RSUs was approximately
$14.2
million as of
October 31, 2017.
This cost is expected to be recognized over a weighted-average period of approximately
2.9
years.
 
 
 
SAR Information
 
The weighted average assumptions used to value SARs granted in the
nine
months ended
October 31, 2017
and
2016
are shown in the following table:
 
   
Nine
Months Ended
October
31,
 
   
2017
   
2016
 
Expected life in years
(1)
   
5.50
     
5.25
 
Risk free interest rate
(2)
   
1.82
%
   
1.16
%
Volatility
(3)
   
33
%
   
36
%
Dividend rate
(4)
   
0.91
%
   
1.51
%
 
____________________________
(
1
)
The expected life of SARs granted under the stock-based compensation plans
is based on historical vested SAR exercise and post-vest forfeiture patterns and includes an estimate of the expected term for SARs that were fully vested and outstanding.
 
(
2
)
The risk-free interest rate is based on the U.S. Treasury yield for a term co
nsistent with the expected life of SARs in effect at the time of grant.
 
(
3
)
The Company estimates the volatility of its common stock at the date of grant based on the historical volatility of the Company
’s common stock for a period equivalent to the expected life of the SARs, which it believes is representative of the expected volatility over the expected life of the SARs.
 
(
4
)
The Company expects to continue paying quarterly dividends at the same rate as the
nine
months ending on
October 31, 2017.
 
The following table summarizes the activity for outstanding SARs for the
nine
months ended
October 31, 2017:
 
   
SARs
(in thousands)
   
Weighted
Average
Exercise
Price per
Share
   
Weighted
Average
Remaining
Contractual
Term (years)
   
Aggregate
Intrinsic
Value
(in thousands)
 
Outstanding at January 31, 2017
   
2,793
    $
15.51
     
 
     
 
 
Granted
   
380
     
31.65
     
 
     
 
 
Exercised
   
(127
)
   
10.54
     
 
     
 
 
Expired
   
(10
)
   
9.75
     
 
     
 
 
Forfeited
   
     
     
 
     
 
 
Outstanding at
October 31, 2017
   
3,036
    $
17.75
     
4.2
    $
56,056
 
Vested and exercisable at
October 31, 2017
   
2,085
    $
14.23
     
3.1
    $
45,683
 
 
The aggregate intrinsic value in the table above represents the total pretax intrinsic value (the aggregate difference between the closing stock price of the Company
’s common stock based on the last trading day as of
October 31, 2017,
and the exercise price for in-the-money SARs) that would have been received by the holders if all SARs had been exercised on
October 31, 2017.
The total intrinsic value of SARs exercised in the
nine
months ended
October 31, 2017
was
$2.7
million. The weighted average grant date fair value per share of SARs granted in the
nine
months ended
October 31, 2017
and
2016
was
$9.59
and
$5.43,
respectively.
No
SARs were granted in the
three
months ended
October 31, 2017
and
2016.
 
The number of SARs exercised includes shares withheld on behalf of employees to satisfy minimum statutory tax withholding requirements.
  During the
three
months ended
October 31, 2017,
the Company withheld
12,000
shares for payment of these taxes at a value of
$0.4
million. During the
nine
months ended
October 31, 2017,
the Company withheld
28,000
shares for payment of these taxes at a value of
$0.9
million.
 
At
October 31, 2017,
there was approximately
$6.4
million of total unrecognized compensation cost related to unvested SARs. This cost is expected to be recognized over a weighted-average period of approximately
2.8
years.